Google
 
Google

World Stem Cell Summit 2010

Monday, January 28, 2008

Nature Clinical Practice Cardiovascular Medicine - Table of Contents alert Volume 5 Issue 2

NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE

February 2008 Volume 5 Number 2

Visit Nature Clinical Practice Cardiovascular Medicine online to
browse the journal.

Now available at http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0VNw0E1

=====================================================================

Calling now for original research submissions

Maximise the visibility and impact of your research and be one of the
first to be published in the new Nature Clinical Practice
Cardiovascular Medicine Clinical Research section.

To find out more visit

http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BibC0Et

=====================================================================

Focus on cardiac assist devices

This special issue features several articles, covering a broad spectrum
of themes in cardiac assist device therapy, written by experts in the
field - from a 'where are we now' appraisal of left ventricular assist
devices for heart failure, to the use of a total artificial heart in
patients with protracted refractory cardiogenic shock.

=====================================================================

----------------------
EDITORIAL
----------------------
Focus on mechanical assist devices for the treatment of heart failure
Philip A Poole-Wilson
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmBo0EB

----------------------
VIEWPOINTS
----------------------
Long-term left-ventricular-assist-device therapy is here to stay
Magdi H Yacoub and Leslie W Miller
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmBp0EC

New percutaneous mechanical left ventricular support for acute MI:
the AMC MACH program
Jose PS Henriques and Bas AJM de Mol
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmBq0ED

The total artificial heart in refractory cardiogenic shock: saving the
patient versus saving the heart
Marvin J Slepian and Jack G Copeland
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmBr0EE

----------------------
RESEARCH HIGHLIGHTS
----------------------
Low HDL despite statin-lowered LDL cholesterol levels raises risk of
cardiovascular events
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmBs0EF

ICDs for heart failure are more commonly used among white men
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmBt0EG

PFO closure without a permanent implant is safe and feasible
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmBu0EH

The diagnostic accuracy of electrocardiographic indices for LV hypertrophy
is poor
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmBv0EI

Substantial weight gain precedes hospitalization for heart failure
decompensation
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmBw0EJ

Effectiveness of ACE inhibition in patients with Marfan's syndrome on
[beta]-blockade
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmBx0EK

Sirolimus-eluting stents can be used in patients with diabetes and
coronary artery disease
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmBy0EL

New survey reveals global extent of obesity crisis
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmBz0EM

Physical activity reduces overall CVD risk by influencing known risk
factors
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmB10E8

Heritability of left main coronary disease and risk of future events
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmB20EA

Measuring proBNP identifies dyspnea caused by cardiac disease
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmB30EB

Cardiac troponin levels predict death in patients stabilized after acute
coronary syndromes
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmB40EC

Research supports establishment of specialized TIA clinics
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmB50ED

Antibiotic improves outcome following acute stroke
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmB60EE

----------------------
PRACTICE POINTS
----------------------
Re-examining aggressive anticoagulant therapy: the case of acute coronary
syndromes
Mark Crowther and Wendy Lim
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmB70EF

Pediatric rheumatic heart disease in the developing world:
echocardiographic versus clinical screening
Jonathan R Carapetis
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmB80EG

Can ICDs prevent sudden cardiac death effectively in patients with
hypertrophic cardiomyopathy?
Alan Kadish
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmCA0EQ

Progenitor cell therapy and myocardial infarction: the importance of
microvascular function
Christian Werner, Michael Bohm and Erik B Friedrich
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmCB0ER

A new continuous-flow LV assist device for patients with end-stage
heart failure
Eric A Rose
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmCC0ES

Can a pulsatile left ventricular assist device provide destination
therapy for patients with severe heart failure?
Soon J Park
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmCD0ET

----------------------
REVIEWS
----------------------
Patient selection for percutaneous mitral valve repair: insight from
early clinical trial applications
Ted Feldman and Donald Glower
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmCE0EU

Rapid regression of atherosclerosis: insights from the clinical and
experimental literature
Kevin Jon Williams, Jonathan E Feig and Edward A Fisher
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmCF0EV

The aging hypertensive heart: a brief update
Dinko Susic and Edward D Frohlich
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmCG0EW

----------------------
CASE STUDY
----------------------
A case of vagally mediated idiopathic ventricular fibrillation
Masaharu Kataoka, Seiji Takatsuki, Kojiro Tanimoto, Makoto Akaishi,
Satoshi Ogawa and Hideo Mitamura
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmCH0EX

----------------------
ARTICLE RESPONSE
----------------------
Pheochromocytoma
Bas Havekes and Karel Pacak
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmCI0EY

=====================================================================

TOP TEN CARDIOLOGY ARTICLES

NEW! View the ten most popular articles from last month's issue of
Nature Clinical Practice Cardiovascular Medicine.

Articles are ranked according to the number of times they have been
downloaded.

http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0BmCJ0EZ

=====================================================================

You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/eiqp0Xztnp0HjH0Zzu0Em
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact our customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston

=====================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time